Sivam Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.11 Cr
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.77 Cr
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth -69.20%
- Profit Growth -80.78%
- Ebitda -37.67%
- Net Worth 1.18%
- Total Assets -59.46%
About Sivam Remedies
Sivam Remedies Private Limited (SRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 March 2012 and has a history of 12 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.11 Cr.
The company currently has active open charges totaling ₹6.77 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Subalakshmi and Sivakumar Sathiah serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TN2012PTC085076
- Company No.
085076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sivam Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subalakshmi  | Director | 21-Mar-2012 | Current |
| Sivakumar Sathiah | Director | 21-Mar-2012 | Current |
Financial Performance of Sivam Remedies.
Sivam Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 69.2% decrease. The company also saw a substantial fall in profitability, with a 80.78% decrease in profit. The company's net worth moved up by a moderate rise of 1.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sivam Remedies?
In 2023, Sivam Remedies had a promoter holding of 99.28% and a public holding of 0.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.77 Cr
₹3.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 6.77 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2018 | State Bank Of India | ₹6.77 Cr | Open |
| 18 Jan 2014 | Others | ₹3.00 Cr | Satisfied |
How Many Employees Work at Sivam Remedies?
Sivam Remedies has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sivam Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sivam Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.